No Picture
News

Ocelot Bio Presents Phase 1 Data Highlighting Activity and Safety of OCE-205 at AASLD The Liver Meeting®

SAN DIEGO–(BUSINESS WIRE)– #AASLD22–Ocelot Bio, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics to treat complications of end-stage liver disease (ESLD), today announces results from the completed Phase 1 healthy volunteer […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update

SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Wugen to Present Data on WU-NK-101 for Relapsed / Refractory Acute Myelogenous Leukemia at The American Society of Hematology’s (ASH) 64th Annual Meeting

ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced an upcoming presentation highlighting […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Equillium Announces Presentation at the 6th Annual Dermatology Drug Development Summit

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced a presentation at the […]

No Picture
News

Lineage Cell Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on November 10, 2022

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it will report its third quarter 2022 […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022

SAN DIEGO, Nov. 2, 2022 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its second […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

STAT+: Pharmalittle: FDA panel urges improved regulation of pulse oximeters; CVS Health agrees to $5 billion settlement over opioid lawsuits

Good morning from San Diego. I’m Jonathan Wosen, STAT’s West Coast biotech reporter, and I’m picking up the baton from Drew as we continue to fill in for Ed this week. To kickstart my morning, […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Equillium Announces Initiation of Phase 1 study of EQ102, A First-in-Class Multi-Cytokine Inhibitor of IL-15 and IL-21 Targeting Celiac Disease

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ #celiac–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it has […]

No Picture
News

AHEAD STUDY IS FIRST TO TEST LECANEMAB TO DELAY OR PREVENT ALZHEIMER’S DISEASE SYMPTOMS AT THE STAGE OF PRECLINICAL AD

SAN DIEGO, Nov. 2, 2022 /PRNewswire/ — The Alzheimer’s Clinical Trial Consortium (ACTC) will be presenting analyses of screening plasma and neuroimaging data from the AHEAD Study at CTAD in November. The AHEAD Study is […]